OKLAHOMA MEDICAL RESEARCH FOUNDATION
Patent Owner
Stats
- 109 US PATENTS IN FORCE
- 7 US APPLICATIONS PENDING
- Oct 05, 2017 most recent publication
Details
- 109 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,623 Total Citation Count
- Oct 29, 1987 Earliest Filing
- 127 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0247,462 TREATMENT OF MULTIPLE SCLEROSIS AND NEUROMYELITIS OPTICAJun 29, 15Aug 31, 17[A61K, G01N, C07K]
2014/0128,276 CYTOKINE PROFILES AS METHODS FOR DIAGNOSIS AND PROGNOSIS OF IRRITABLE BOWEL SYNDROMEJan 13, 12May 08, 14[G01N]
2013/0197,028 nAChRalpha7 Agonists and nAChRalpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD)Jun 24, 11Aug 01, 13[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9556266 Methods of treating sickle cell disease with anti-P-selectin antibodiesFeb 01, 13Jan 31, 17[A61K, C07K]
9511095 Cells treated by in vitro fucosylation and methods of production and use thereofMay 14, 13Dec 06, 16[A61K, C12N]
9453204 Production of pluripotent cells through inhibition of bright/ARID3a functionJul 10, 09Sep 27, 16[C12N]
9200324 Biomarkers and methods for measuring and monitoring inflammatory disease activityOct 15, 10Dec 01, 15[C12Q, G01N, G06F]
9127072 Methods of treating hemophilia using monoclonal antibodies against activated protein CNov 29, 11Sep 08, 15[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0258,168 MODULATION OF PODOPLANIN MEDIATED PLATELET ACTIVATIONAbandonedSep 12, 13Sep 17, 15[A61K, C12N, C07K]
2015/0098,940 Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and FlareAbandonedOct 02, 14Apr 09, 15[G01N]
2014/0302,013 PREDICTING AND DIAGNOSING PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSAbandonedApr 08, 14Oct 09, 14[C12Q]
2014/0066,488 Inhibitors of Memapsin 2 Cleavage for the Treatment of Alzheimer's DiseaseAbandonedAug 28, 13Mar 06, 14[A61K, C07D, C07C]
2014/0005,071 Method of Using Cytokine Assays to Diagnose, Treat, and Evaluate Inflammatory DiseaseAbandonedSep 03, 13Jan 02, 14[G01N]
2013/0303,391 METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILESAbandonedSep 14, 11Nov 14, 13[G01N]
2013/0225,694 COMPOSITIONS AND METHODS OF INHIBITING RETINAL DEGENERATIONAbandonedFeb 25, 13Aug 29, 13[A61K]
2013/0209,366 Glutathione-Lanthionine Compounds and Methods Related TheretoAbandonedAug 24, 11Aug 15, 13[A61K, C07K]
2013/0073,213 Gene Expression-Based Differential Diagnostic Model for Rheumatoid ArthritisAbandonedSep 17, 12Mar 21, 13[G06F]
2012/0258,883 METHOD OF USING CYTOKINE ASSAYS TO DIAGNOSE, TREAT, AND EVALUATE INFLAMMATORY AND AUTOIMMUNE DISEASESAbandonedMay 09, 12Oct 11, 12[C40B]
2012/0197,059 UBIQUITIN INTERACTING MOTIF PEPTIDES AS CANCER THERAPEUTICSAbandonedJan 31, 12Aug 02, 12[A61K, A61P, A61N]
2012/0116,685 Methods, System, And Medium For Associating Rheumatoid Arthritis Subjects With Cardiovascular DiseaseAbandonedApr 05, 10May 10, 12[G06F]
2011/0212,096 ANTI-P-SELECTIN ANTIBODIES AND METHODS OF THEIR USE AND IDENTIFICATIONAbandonedDec 21, 10Sep 01, 11[A61K, C07H, C12N, A61P, C07K]
2011/0183,891 Methods and Compositions for Inhibiting Fungal Infection and DiseaseAbandonedDec 14, 10Jul 28, 11[A61K, C12N, A61P, C07K]
2011/0110,954 Anthrax compositions and methods of use and productionAbandonedSep 13, 10May 12, 11[A61K, G01N, A61P, C07K]
7829669 Catalytically active recombinant memapsin and methods of use thereofExpiredAug 03, 07Nov 09, 10[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.